Vertex Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Vertex heeft een totaal eigen vermogen van $258.9M en een totale schuld van $337.5M, wat de schuld-eigenvermogensverhouding op 130.3% brengt. De totale activa en totale passiva bedragen respectievelijk $1.3B en $1.0B. De EBIT Vertex is $4.7M waardoor de rentedekking -0.9 is. Het heeft contanten en kortetermijnbeleggingen van $314.0M.
Belangrijke informatie
130.34%
Verhouding schuld/eigen vermogen
US$337.48m
Schuld
| Rente dekkingsratio | -0.9x |
| Contant | US$314.01m |
| Aandelen | US$258.92m |
| Totaal verplichtingen | US$1.01b |
| Totaal activa | US$1.27b |
Recente financiële gezondheidsupdates
Vertex (NASDAQ:VERX) Has A Pretty Healthy Balance Sheet
Jul 22
Does Vertex (NASDAQ:VERX) Have A Healthy Balance Sheet?
Feb 07Health Check: How Prudently Does Vertex (NASDAQ:VERX) Use Debt?
Apr 18Recent updates
VERX: Rebased Multiple And 2026 Execution On AI Tax Platform Will Drive Repricing
Vertex's updated analyst price target has been lowered by several firms, trimming estimates by $2 to $13 as analysts reassess underlying metrics and reset expectations, despite relatively steady assumptions for growth, margins and valuation multiples. Analyst Commentary Across the recent research updates, analysts are revisiting their models on Vertex and adjusting price targets, but many are keeping their core assumptions on growth, margins and valuation frameworks relatively steady.VERX: Rebased Multiple And 2026 Execution On Guidance Will Drive Repricing
Vertex's analyst price targets have been trimmed by between $2 and $13 as analysts factor in updated views on key operating metrics and valuation multiples. Analyst Commentary Recent research updates on Vertex point to a period of recalibration, with several firms trimming price targets and reassessing ratings as they incorporate new views on operating metrics and valuation multiples.
VERX: AI Tax Partnerships Will Offset Execution Risk As Expectations Reset
Vertex's updated analyst price target has been reduced by a cluster of recent revisions that include cuts of $2 to $13 from multiple firms. Analysts point to changes in underlying metrics, a slightly higher discount rate and revenue growth outlook, and a marginally lower future P/E assumption.VERX: Rebased Earnings Multiple And 2026 Guidance Will Drive Future Repricing
Vertex's updated fair value narrative falls to $25.00 from $50.00 as analysts trim price targets across the Street and factor in adjusted growth, profitability, discount rate, and future P/E assumptions. Analyst Commentary Recent Street research on Vertex has centered on recalibrated price targets, with several firms adjusting their models for growth, profitability, and P/E assumptions.VERX: AI Tax Partnership Will Face Higher Execution Risk After Earnings Reset
Vertex's analyst price target has been cut by a cluster of firms, with reductions ranging from $2 to $13, as analysts point to weaker underlying metrics and revised earnings assumptions. Analyst Commentary Recent research highlights a clear tilt toward caution, with multiple bearish analysts revisiting their models and trimming expectations for Vertex.There May Be Underlying Issues With The Quality Of Vertex's (NASDAQ:VERX) Earnings
Feb 18VERX: AI Tax Partnership And Margin Reset Will Shape Future Risk Reward
The analyst price target for Vertex has been reduced from $22 to $13, with analysts citing recent cuts across the Street and a reset of profit margin and future P/E assumptions as key drivers of the change. Analyst Commentary Across recent research, bearish analysts have been resetting expectations on Vertex with a series of price target cuts and rating downgrades.Vertex: Buy At Ultracheap Multiples, Product Is Safe From AI
Feb 11Vertex, Inc.'s (NASDAQ:VERX) Popularity With Investors Under Threat As Stock Sinks 25%
Feb 11VERX: AI Compliance Partnership Will Offset Execution Risks Over Time
Analysts have trimmed their fair value estimate for Vertex to US$22 from US$25, reflecting lower published price targets and updated models that incorporate reduced growth expectations, thinner profit margins and new headwinds highlighted in recent research. Analyst Commentary Recent Street research highlights a clear reset in expectations for Vertex, with a series of reduced price targets and cautious tones around the company’s updated outlook.
VERX: CEO Transition And 2026 Focus Will Support Share Rebound
Our Analyst Price Target for Vertex edges down from about $27.86 to $27.29 as analysts trim growth and fair value assumptions, following lowered Street targets tied to softer guidance, moderating ARR trends, and questions around execution after the CEO transition. Analyst Commentary Recent Street research on Vertex clusters around a reset in expectations after Q3 results, updated guidance, and the CEO transition.VERX: Shares Will Rebound As CEO Transition Unlocks Long Term Reacceleration
Analysts have modestly lowered our Vertex price target to the mid 20 dollar range, trimming expectations by several dollars as they incorporate softer guidance, slower ARR growth, and a more challenging path to reacceleration despite still supportive longer term fundamentals. Analyst Commentary Street research following the latest print reflects a more cautious stance on Vertex, with most models recalibrated to slower near term growth, lower ARR contribution, and a steeper path to achieving the long term reacceleration framework.VERX: Shares Will Recover As CEO Transition And Buyback Support Turnaround
Vertex's average analyst price target has been lowered by several dollars to the mid 20 dollar range, as analysts factor in mixed Q3 results, reduced guidance, softer ARR growth, and a more challenging near term outlook, despite longer term growth levers and a solid competitive position. Analyst Commentary Street research following the Q3 print reflects a more cautious posture on Vertex in the near term, with most models recalibrated to lower growth and margin trajectories, but also recognition that the long term opportunity and competitive positioning remain intact.VERX: Shares Will Recover As CEO Transition Restores Confidence
Vertex's consensus analyst price target has been reduced by several dollars into the mid 20 dollar range, as analysts recalibrate their models to reflect mixed Q3 results, lowered guidance, a disappointing Q4 and FY25 outlook, and concerns around slowing ARR growth and execution during the CEO transition. Analyst Commentary Street research following the Q3 print and guidance reset reflects a more cautious but still divided view on Vertex's medium term prospects.VERX: Shares Will Rebound As CEO Transition Drives Long-Term Stability
Vertex's analyst price target has been lowered significantly, falling from over $36 to under $28 per share. Analysts cite softened revenue growth, reduced margin outlooks, and ongoing business challenges following disappointing quarterly results and guidance updates.Some Confidence Is Lacking In Vertex, Inc. (NASDAQ:VERX) As Shares Slide 25%
Nov 07VERX: Upcoming Leadership Transition Will Shape Future Market Positioning
The analyst price target for Vertex has been reduced from $35 to $28. Analysts point to continued revenue retention challenges and leadership uncertainty, despite stable results and a strong market position.More Unpleasant Surprises Could Be In Store For Vertex, Inc.'s (NASDAQ:VERX) Shares After Tumbling 26%
Aug 26European E-Invoicing Mandates And ERP Migrations Will Expand Markets
With Vertex’s key metrics—Future P/E and Net Profit Margin—remaining effectively unchanged, analyst sentiment and fair value estimates are stable, as reflected in the unchanged consensus price target of $44.85. What's in the News Vertex reduced full-year 2025 earnings guidance due to extended sales cycles and delayed customer decision-making, now expecting revenues of $750-$754 million.Vertex's (NASDAQ:VERX) Returns On Capital Are Heading Higher
Aug 06Vertex (NASDAQ:VERX) Has A Pretty Healthy Balance Sheet
Jul 22Risks To Shareholder Returns Are Elevated At These Prices For Vertex, Inc. (NASDAQ:VERX)
Jun 26Vertex's (NASDAQ:VERX) Returns On Capital Are Heading Higher
Apr 07Vertex: Expectations Reset With Improved Fundamentals (Rating Upgrade)
Mar 26Vertex, Inc. (NASDAQ:VERX) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Feb 26Does Vertex (NASDAQ:VERX) Have A Healthy Balance Sheet?
Feb 07Vertex: Risky Valuation Amid Shaky Organic Growth
Jan 21Vertex, Inc.'s (NASDAQ:VERX) Shares Climb 28% But Its Business Is Yet to Catch Up
Nov 22Vertex, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Nov 09There's Been No Shortage Of Growth Recently For Vertex's (NASDAQ:VERX) Returns On Capital
Oct 24
Ecosio Integration And AI Advancements Propel The Company Into A Global Tax Compliance Leader
Integrating ecosio's technology and acquiring AI capabilities signal strong potential for new market opportunities and enhanced operational efficiencies, aiming at revenue and subscription growth.Vertex, Inc.: Growth Momentum Continues With FCF Conversion Rates Inflecting Upwards
Aug 21Vertex's (NASDAQ:VERX) Performance Is Even Better Than Its Earnings Suggest
Aug 14Calculating The Intrinsic Value Of Vertex, Inc. (NASDAQ:VERX)
Aug 02Pinning Down Vertex, Inc.'s (NASDAQ:VERX) P/S Is Difficult Right Now
Jun 10Health Check: How Prudently Does Vertex (NASDAQ:VERX) Use Debt?
Apr 18Vertex: EPS Better Than Expected, Cloud Offerings, And Cheap
Mar 19A Look At The Fair Value Of Vertex, Inc. (NASDAQ:VERX)
Nov 13An Intrinsic Calculation For Vertex, Inc. (NASDAQ:VERX) Suggests It's 30% Undervalued
Aug 14Vertex, Inc. (NASDAQ:VERX) Investors Are Less Pessimistic Than Expected
May 22Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $560.7M ) van VERX } dekken niet de korte termijn passiva ( $574.7M ).
Langlopende schulden: De kortetermijnactiva VERX ( $560.7M ) overtreffen de langetermijnschulden ( $437.3M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 9.1% ) VERX wordt als voldoende beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van VERX is de afgelopen 5 jaar gestegen van 0% naar 130.3%.
Schuldendekking: De schuld van VERX wordt goed gedekt door de operationele kasstroom ( 49.1% ).
Rentedekking: VERX verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.
Balans
Ontdek gezonde bedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/01 03:48 |
| Aandelenkoers aan het einde van de dag | 2026/05/01 00:00 |
| Inkomsten | 2025/12/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Vertex, Inc. wordt gevolgd door 21 analisten. 14 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Robert Oliver | Baird |
| Andrew DeGasperi | Berenberg |
| Daniel Jester | BMO Capital Markets Equity Research |